Citations

Mayo Clinic

Clear

2436 citation(s) found for "Ly, Amy".

Decline in ACEI/ARB Prescribing as Heart Failure Core Metrics Improve During Computer-Based Clinical Decision Support
Naessens, James M. , Klarich, Mark J., Leutink, Dorinda J., Peterson, James A. , Wagie, Amy E., Manning, Dennis M., Qian, Qi , Caraballo, Pedro J.

American Journal of Medical Quality | November 19, 2013 | Volume: 29 | Issue: 4 | Pages: 300-307

10.1177/1062860613509265 | PMID 24249835 Get It

Aquaporin 4 IgG Serostatus and Outcome in Recurrent Longitudinally Extensive Transverse Myelitis
Jiao, Yujuan , Fryer, James P., Lennon, Vanda A. , McKeon, Andrew , Jenkins, Sarah M. , Quek, Amy May Lin, Weinshenker, Brian G. , Wingerchuk, Dean M. , Shuster, Elizabeth A., Lucchinetti, Claudia F. , Pittock, Sean J. , Smith, Carin Y. , Quek, Amy M L, Pittock, S J , Weinshenker, Brian G , McKeon, Andrew , Quek, Amy M.L.

JAMA Neurology | November 18, 2013 | Volume: 71 | Issue: 1 | Pages: 48

10.1001/jamaneurol.2013.5055 | PMID 24248262 Get It

Paraneoplastic and Autoimmune Encephalopathies
Clardy, Stacey , Quek, Amy Lin, O’Toole, Orna , O'Toole, Orna, Quek, Amy M.L. , Clardy, Stacey L

Seminars in Neurology | November 14, 2013 | Volume: 33 | Issue: 04 | Pages: 357-364

10.1055/s-0033-1359318 | PMID 24234357 Get It

Safety Studies on Intravenous Administration of Oncolytic Recombinant Vesicular Stomatitis Virus in Purpose-Bred Beagle Dogs
Naik, Shruthi , Galyon, Gina D., Jenks, Nathan, Steele, Mike, Peng, Kah-Whye , Federspiel, Mark J. , Donnell, Robert L. , Russell, Stephen J. , LeBlanc, Amy Kathleen , Jenks, Nathan J., Russell, Stephen J

Human Gene Therapy Clinical Development | November 12, 2013 | Volume: 24 | Issue: 4 | Pages: 174-181

10.1089/humc.2013.165 | PMID 24219832 Get It

Health-related quality of life in children and young adults with post-thrombotic syndrome: Results from a cross-sectional study
Kumar, Riten , Rodriguez, Vilmarie , Matsumoto, Jane M., Khan, Shakila P. , Weaver, Amy L. , McBane, Robert D. , Beebe, Timothy J. , Heit, John A. , McBane, Robert , Kumar, Riten

Pediatric Blood & Cancer | November 6, 2013 | Volume: 61 | Issue: 3 | Pages: 546-551

10.1002/pbc.24840 | PMID 24347376 Get It

CutaneousT‐cell lymphoma in patients with chronic lymphocytic leukemia: clinical characteristics, temporal relationships, and survival data in a series of 14 patients atMayoClinic
Chang, Michael B., Weaver, Amy L. , Brewer, Jerry D.

International Journal of Dermatology | October 18, 2013 | Volume: 53 | Issue: 8 | Pages: 966-970

10.1111/ijd.12063 | PMID 24134412 Get It

AbstractBackgroundWe examined the course of cutaneous T‐cell lymphoma (CTCL), which has been associated with chronic lymphocytic leukemia (CLL) in patients withCLL.Materials and methodsA search was conducted of the master diagnosis index at our institution to identify patients with bothCLLandCTCLfrom 1980 to 2010. A retrospective chart review was then conducted.ResultsOf the 14 patients withCTCLandCLL, eight had mycosis fungoides (MF; two with patch stage, two with plaque stage, two with tumor stage, and two with erythrodermic stage), four had Sézary syndrome, one had natural killer cell lymphoma involving the skin, and one had peripheral T‐cell lymphoma involving the skin. Eight had concurrent diagnoses, five received aCLLdiagnosis first, and one received aCTCLdiagnosis first. Ten patients were deceased at the time of data abstraction due to unknown causes (n = 4), lymphoma (n = 2), pneumonia (n = 2),MF(n = 1), or respiratory failure (n = 1). Of the nine patients with concurrent or priorCTCL, seven were deceased, with a median time to death of 10.2 months (range, 6–89 months). Of the five patients withCLLprior toCTCL, three were deceased at 18, 27, and 47 months, respectively, after theCTCLdiagnosis. The median survival for the two groups was 12 and 47 months, respectively.ConclusionsPatients withCTCLconcurrent with or prior toCLLhave a worse overall survival than patients withCLLin whomCTCLlater develops. Larger studies are needed.
Vertebral Body Infarct and Ventral Cauda Equina Enhancement: Two Confirmatory Findings of Acute Spinal Cord Infarct
Schwartz, Kara M., Eckel, Laurence J. , Black, David F. , Wood, Christopher P. , Kotsenas, Amy L. , Wald, John T. , Hocker, Sara E. , Diehn, Felix E. , Hunt, Christopher H. , Lehman, Vance T. , Halaweish, Ahmed F

Journal of Neuroimaging | October 12, 2013 | Volume: 25 | Issue: 1 | Pages: 133-135

10.1111/jon.12058 | PMID 24118402 Get It

ABSTRACTTwo valuable confirmatory MRI findings of acute spinal cord infarct are highlighted and discussed: concomitant vertebral body infarct and ventral cauda equina nerve root enhancement.
Three‐dimensional volumetric computed tomographic scoring as an objective outcome measure for chronic rhinosinusitis: clinical correlations and comparison to Lund‐Mackay scoring
Pallanch, John F., Yu, Lifeng , DeLone, David R. , Robb, Rich, Holmes, David R. , Camp, Jon J. , Edwards, P D, Ponikau, Jens U., Dearking, Amy C., Lane, John I. , Primak, Andrew N. , Shinkle, Aaron, Frigas, Evangelo, Ocel, Joseph J., Tombers, Nicole M. , Siwani, Rizwan, Orme, Nicholas M., Reed, Kurtis B., Jerath, Nivedita U. , Dhillon, Robinder, Kita, Hirohito , Yu, Lifeng , McCollough, Cynthia H. , Hagan, John P. , Kita, H

International Forum of Allergy & Rhinology | October 8, 2013 | Volume: 3 | Issue: 12 | Pages: 963-972

10.1002/alr.21219 | PMID 24106202 Get It

BackgroundWe aimed to test the hypothesis that three‐dimensional (3D) volume‐based scoring of computed tomography (CT) images of the paranasal sinuses was superior to Lund‐Mackay CT scoring of disease severity in chronic rhinosinusitis (CRS). We determined correlation between changes in CT scores (using each scoring system) with changes in other measures of disease severity (symptoms, endoscopic scoring, and quality of life) in patients with CRS treated with triamcinolone.MethodsThe study group comprised 48 adult subjects with CRS. Baseline symptoms and quality of life were assessed. Endoscopy and CT scans were performed. Patients received a single systemic dose of intramuscular triamcinolone and were reevaluated 1 month later. Strengths of the correlations between changes in CT scores and changes in CRS signs and symptoms and quality of life were determined.ResultsWe observed some variability in degree of improvement for the different symptom, endoscopic, and quality‐of‐life parameters after treatment. Improvement of parameters was significantly correlated with improvement in CT disease score using both CT scoring methods. However, volumetric CT scoring had greater correlation with these parameters than Lund‐Mackay scoring.ConclusionVolumetric scoring exhibited higher degree of correlation than Lund‐Mackay scoring when comparing improvement in CT score with improvement in score for symptoms, endoscopic exam, and quality of life in this group of patients who received beneficial medical treatment for CRS.
Lifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Domecq, Juan Pablo , Prutsky, Gabriela, Mullan, Rebecca J., Hazem, Ahmad, Sundaresh, Vishnu , Elamin, Mohammed B., Phung, Olivia J, Wang, Amy , Hoeger, Kathleen M. , Pasquali, Renato, Erwin, Patricia J., Bodde, Amy E. , Montori, Víctor M. , Murad, M. Hassan , Murad, M Hassan , Montori, Victor M , Domecq Graces, Juan Pablo

The Journal of Clinical Endocrinology & Metabolism | October 4, 2013 | Volume: 98 | Issue: 12 | Pages: 4655-4663

10.1210/jc.2013-2385 | PMID 24092832 Get It

Context: Polycystic ovary syndrome (PCOS) is a prevalent disorder that affects women of childbearing age and may be related to obesity and insulin resistance. Objective: The purpose of this systematic review was to appraise the evidence of the impact of lifestyle modification (LSM) interventions on outcomes of women with PCOS. Data Sources: Sources included Ovid Medline, OVID Embase, OVID Cochrane Library, Web of Science, Scopus, PsycINFO, and CINAHL (up to January 2011). Study Selection: We included randomized controlled trials that enrolled woman of any age with PCOS who received LSM and compared them against women who received no intervention, minimal intervention, or metformin. Data Extraction: Two authors performed the data extraction independently. Data Synthesis: We included 9 trials enrolling 583 women with a high loss to follow-up rate, lack of blinding, and short follow-up. Compared with minimal intervention, LSM significantly reduced fasting blood glucose (weighted mean difference, −2.3 mg/dL; 95% confidence interval, −4.5 to −0.1, I2 = 72%, P = .04) and fasting blood insulin (weighted mean difference, −2.1 μU/mL, 95% confidence interval, −3.3 to −1.0, I2 = 0%, P < .001). Changes in body mass index were associated with changes in fasting blood glucose (P < .001). Metformin was not significantly better than LSM in improving blood glucose or insulin levels. We found no significant effect of LSM on pregnancy rate, and the effect on hirsutism was unclear. Conclusions: The available evidence suggests that LSM reduces fasting blood glucose and insulin levels in women with PCOS. Metformin has similar effects. Translation of these short-term effects to patient-important outcomes, beyond diabetes prevention, remains uncertain.
A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I
Worcester, Elaine M. , Evan, Andrew P., Coe, Fredric L. , Lingeman, James E., Krambeck, Amy E. , Sommers, Andre, Phillips, Carrie L. , Milliner, Dawn S.

American Journal of Physiology-Renal Physiology | October 3, 2013 | Volume: 305 | Issue: 11 | Pages: F1574-F1584

10.1152/ajprenal.00382.2013 | PMID 24089413 Get It

The sequence of events by which primary hyperoxaluria type 1 (PH1) causes renal failure is unclear. We hypothesize that proximal tubule (PT) is vulnerable because oxalate secretion raises calcium oxalate (CaOx) supersaturation (SS) there, leading to crystal formation and cellular injury. We studied cortical and papillary biopsies from two PH1 patients with preserved renal function, and seven native kidneys removed from four patients at the time of transplant, after short-term ( 2 ) or longer term ( 2 ) dialysis. In these patients, and another five PH1 patients without renal failure, we calculated oxalate secretion, and estimated PT CaOx SS. Plasma oxalate was elevated in all PH1 patients and inverse to creatinine clearance. Renal secretion of oxalate was present in all PH1 but rare in controls. PT CaOx SS was >1 in all nonpyridoxine-responsive PH1 before transplant and most marked in patients who developed end stage renal disease (ESRD). PT from PH1 with preserved renal function had birefringent crystals, confirming the presence of CaOx SS, but had no evidence of cortical inflammation or scarring by histopathology or hyaluronan staining. PH1 with short ESRD showed CaOx deposition and hyaluronan staining particularly at the corticomedullary junction in distal PT while cortical collecting ducts were spared. Longer ESRD showed widespread cortical CaOx, and in both groups papillary tissue had marked intratubular CaOx deposits and fibrosis. CaOx SS in PT causes CaOx crystal formation, and CaOx deposition in distal PT appears to be associated with ESRD. Minimizing PT CaOx SS may be important for preserving renal function in PH1.